Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 401 results for "Shionogi"

Shionogi fights patent expiration headache with new drugs
Nikkei Asian Review

Shionogi fights patent expiration headache with new drugs

OSAKA -- Anchoring its future on unique and innovative drugs developed through its own mettle, Shionogi is a bright spot in a Japanese pharmaceutical industry marred by overseas woes. Among Japanese drugmakers, Shionogi comes in 16th or 17th by ... Nikkei Asian Review, 1 week ago

15 images for Shionogi

PR inside, 1 day ago
Nikkei Asian Review, 1 week ago
DesignCurial, 1 month ago
DesignCurial, 1 month ago
DesignCurial, 1 month ago
4 Traders, 2 months ago, 3 months ago, 3 months ago
Bio Spectrum Asia, 4 months ago
Bio Spectrum Asia, 4 months ago

SHIONOGI : Notice of Revision of Dividend Forecasts

03/24/2014 | 02:43am US/Eastern Recommend: 0 Notice of Revision of Dividend Forecasts Osaka, Japan, March 24, 2014 - Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: Isao Teshirogi, Ph.D.; hereafter "Shionogi") today ...
 4 Traders3 weeks ago SHIONOGI : Announces Appointment of Corporate Officer  4 Traders3 weeks ago Shionogi Announces Appointment of Corporate Officer  TMC Net3 weeks ago

PharmaPoint: Postmenopausal Vaginal Atrophy - Global Drug Forecast and Market Analysis to 2022

FEATURED COMPANIES Actavis Bayer AG Novo Nordisk Pfizer Shionogi MORE Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade, it is expected to ...
 Research and Markets1 month ago Recent Study: Personalized Medicine Partnering Terms and Agreements  Digital Journal3 hours ago Clinical Stage Partnering Terms and Agreements in Pharma and Biotech: New Research Report Available at Fast Market Research  Digital Journal1 day ago Global Perennial Allergic Rhinitis Pipeline Review 2014 - Analysis of 10 Company Profiles & 12 Drug Profiles  Individual.com1 day ago

SHIONOGI : Tivicay® Tablets 50mg, HIV Integrase Inhibitor Launched in Japan

PRESS RELEASE April 17, 2014 Tivicay ® Tablets 50mg, HIV Integrase Inhibitor Launched in Japan New Treatment Option for Treatment-nave Patients and Patients Requiring an Alternative to Current Treatment Regime ViiV Healthcare K. K. (Head ...
 4 Traders1 day ago ViiV Healthcare receives MHLW approval for treatment of HIV  Individual.com3 weeks ago New HIV Treatment Launched by ViiV Healthcare Addresses Multiple Evolving Needs of People Living With HIV in the UK  Asian Hospital & Healthcare Management1 month ago

Shionogi : Patent Issued for Prodrugs of (4aS, 13ar)-N--10-Hydroxy-9-11-Dioxo-2,3,4a,5,9,11,-...

Patent Issued for Prodrugs of (4aS, 13ar)-N-[(2,4-Difluorophenyl)methyl]-10-Hydroxy-9-11-Dioxo-2,3,4a,5,9,11,- 13,13a-Octahydro-1H-Pyrido[1,2-A]pyrrolo[1',2':3:4]imidazo[1,2-D]pyrazine-- 8-Carboxamide By a News Reporter-Staff News Editor at AIDS ...
 4 Traders1 day ago

ViiV recalls 1,000 bottles of Tivicay for cross-contamination

Projected blockbuster is the first drug to come out of GSK, Pfizer, Shionogi partnership Share Tools GlaxoSmithKline ($GSK), Pfizer ($PFE) and Shionogi have gotten off to a bit of a rocky start with Tivicay, the first FDA-approved drug to come ...
 FiercePharmaManufacturing3 days ago

GSK stops lung-cancer vaccine trial

The GSK-Pfizer-Shionogi joint venture said it will add HIV med Tivicay to a United Nations patent pool, cutting its price for developing countries and granting access for generics firms. The FDA has issued draft guidance that funds FDA ...
 Medical Marketing And Media2 weeks ago ViiV adds pricey new HIV drug Tivicay to patent pool  FiercePharma2 weeks ago GSK's ViiV unit adds new HIV drug to AIDS patent pool  AlertNet2 weeks ago

SHIONOGI's New Medium-Term Business Plan

SHIONOGI's New Medium-Term
 Noodls3 weeks ago

HIV Therapeutics Market To 2019 Worldwide Industry Share, Investment Trends, Growth, Size, Strategy and Forecast Research Report

The leading business intelligence provider GBI Research has released its latest research report, entitled "HIV Therapeutics Market to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress ...
 Individual.com6 hours ago

Neuropathic Pain - Pipeline Review, H1 2014 - New Report Available

recommends "Neuropathic Pain - Pipeline Review, H1 2014" from Global Markets Direct, now available Boston, MA -- (SBWIRE) -- 04/17/2014 -- Global Markets Direct's, 'Neuropathic Pain - Pipeline Review, H1 2014', provides an overview of the ...
 Digital Journal1 day ago New Market Research Report: Alzheimer's Disease - Pipeline Review, H1 2014  Digital Journal2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Shionogi
Get updated on latest news & your favorite topics right in your inbox!
More     Less